欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/V/0188/001
药品名称Finilac 50 mcg/ml
活性成分
    • cabergoline 50.0 µg/ml
剂型Oral solution
上市许可持有人Le Vet. Beheer B.V.
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Finilac 50 µg/ml
    • Luxembourg (LU)
    • Iceland (IS)
      Finilac 50 míkróg/ml Mixtúra, lausn handa hundum og köttum
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Finilac Oral solution 50µg/ml
    • Austria (AT)
      Finilac 50 Mikrogramm/ml Lösung zum Eingeben für Hunde und Katzen
    • France (FR)
      FINILAC 50 µG/ML
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Finilac vet
    • Lithuania (LT)
    • Estonia (EE)
      Finilac vet
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
      Finilac 50 μg/ml perorální roztok pro psy a kočky
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2014/12/16
最近更新日期2024/01/22
药物ATC编码
    • QG02CB03 cabergoline
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase